Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to COMBINATION THERAPY

OBR Oncology

FDA Approves Irinotecan Liposome Combo in Metastatic Pancreatic Cancer

Hematology/Oncology February 20th 2024

Cancer Therapy Advisor

Combination Treatment of HER2-Positive Early Breast Cancer with High Recurrence Risk

Oncology, Medical February 5th 2024

OBR Oncology

FDA Approves Pembrolizumab Combination for Advanced Cervical Cancer

Hematology/Oncology January 22nd 2024

The New England Journal of Medicine

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C

Oncology, Medical January 2nd 2024

The New England Journal of Medicine

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Oncology, Medical November 13th 2023

Cancer Therapy Advisor

Enfortumab Vedotin Plus Pembrolizumab Nearly Doubles PFS, OS in Bladder Cancer

Oncology, Medical November 6th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form